Naba Alsaha Medical Services Co. (9546) is listed on Nomu of the Saudi Exchange (Tadawul) under sector Health Care Equipment & Svc. Financial data sourced from CMA-mandated XBRL filings via Sahm Screener (sahmscreener.com).

For fiscal year 2025, Naba Alsaha Medical Services Co. reported revenue of SAR 202M, net profit of SAR 28M, and earnings per share of SAR 2.62. Total assets stood at SAR 385M with total equity of SAR 223M and total liabilities of SAR 162M.

Operating cash flow for 2025 was SAR 27M, representing a cash conversion ratio of 0.97 relative to net profit. Free cash flow was SAR 108M.

Earnings quality analysis by Sahm Screener: Of every SAR 1.00 in reported net profit for 2025, SAR 0.97 arrived as operating cash. This indicates High quality earnings based on the cash conversion ratio of 0.97.

Revenue growth from 2024 to 2025: +3.9%. Net profit growth over the same period: +26.4%. 3-year revenue CAGR: 37.3%. 3-year net profit CAGR: 0.7%.

Key financial ratios for 2025: Return on Equity 12.4%, Return on Assets 7.2%, Net Margin 13.6%, Debt to Equity 0.73.

In 2024, Naba Alsaha Medical Services Co. reported revenue of SAR 194M and net profit of SAR 22M, compared to SAR 202M and SAR 28M respectively in 2025.